APA

Roozendaal C., Horst G., Pogány K., van Milligen de Wit A. W., Kleibeuker J. H., Haagsma E. B., Limburg P. C. & Kallenberg C. G. (19981209). Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis. : Advances in experimental medicine and biology.

Chicago

Roozendaal C, Horst G, Pogány K, van Milligen de Wit A W, Kleibeuker J H, Haagsma E B, Limburg P C and Kallenberg C G. 19981209. Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis. : Advances in experimental medicine and biology.

Harvard

Roozendaal C., Horst G., Pogány K., van Milligen de Wit A. W., Kleibeuker J. H., Haagsma E. B., Limburg P. C. and Kallenberg C. G. (19981209). Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis. : Advances in experimental medicine and biology.

MLA

Roozendaal C, Horst G, Pogány K, van Milligen de Wit A W, Kleibeuker J H, Haagsma E B, Limburg P C and Kallenberg C G. Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis. : Advances in experimental medicine and biology. 19981209.